Cargando…
Roflumilast Suppresses Adipogenic Differentiation via AMPK Mediated Pathway
Obesity and related disorders have increasingly become global health problems over the years. In recent years, obesity has been recognized as the most important risk factor for a variety of diseases including cardiovascular diseases, type 2 diabetes, steatohepatitis, and cancer. The medical anti-obe...
Autores principales: | Xu, Wan, Zhang, Jingjing, Xiao, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215703/ https://www.ncbi.nlm.nih.gov/pubmed/34163436 http://dx.doi.org/10.3389/fendo.2021.662451 |
Ejemplares similares
-
Roflumilast reduces myocardial ischemia reperfusion injury in vivo and in vitro by activating the AMPK signaling pathway
por: Liao, Bo, et al.
Publicado: (2023) -
ANGPTL8 promotes adipogenic differentiation of mesenchymal stem cells: potential role in ectopic lipid deposition
por: Tang, Jian, et al.
Publicado: (2022) -
17β-Estradiol Induces Mitophagy Upregulation to Protect Chondrocytes via the SIRT1-Mediated AMPK/mTOR Signaling Pathway
por: Mei, Runhong, et al.
Publicado: (2021) -
AMPK Activation Mediated by Hinokitiol Inhibits Adipogenic Differentiation of Mesenchymal Stem Cells through Autophagy Flux
por: Lee, Ju-Hee, et al.
Publicado: (2018) -
Roflumilast Ameliorates Isoflurane-Induced Inflammation
in Astrocytes via the CREB/BDNF Signaling Pathway
por: Zhang, Chunyuan, et al.
Publicado: (2021)